Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
For the quarter ended September 30, 2026, SUI Group Holdings reported a net income of $47.7 million, a significant recovery from a $44.3 million loss in the prior year, primarily driven by an $82.7 million unrealized gain on digital assets. However, for the nine-month period, the company remains in a net loss position of $42.2 million due to realized losses on digital assets and increased operating expenses.
Pono Capital Four Signs $200M M&A Deal with Blackstar Orbital Technologies Corporation
Pono Capital Four, Inc. entered into an amendment to its existing merger agreement with Blackstar Orbital Technologies Corporation, reducing the base purchase price from $380 million to $200 million. The amendment also increases the shares reserved for the post-closing equity incentive plan and extends the outside closing date from March 31, 2027, to June 30, 2027.
TEN Holdings reported Q3 2026 revenue of $0.64 million, a 17.9% year-over-year increase driven by new customer engagements. The company significantly improved its balance sheet, reducing total liabilities by 74% to $2.0 million and paying down related-party borrowings. Management is focusing on transitioning the business to a SaaS-driven model following the launch of its next-generation Digital Experience Platform.
Term
Q3 2026
“Third quarter revenue increased 17.9% year over year to $640,000, as we completed customer engagements that had been initiated in prior periods and added revenue from new customers.”
Virgilio Torres, Chairman and Chief Executive Officer
“Total liabilities declined by approximately 74%, from $7.7 million at year-end 2025 to $2.0 million, reflecting our continued efforts to simplify our capital structure and improve our financial position.”
Virgilio Torres, Chairman and Chief Executive Officer
TEN Holdings, Inc. reported a net loss of $3.7 million for the third quarter of 2026, with revenue increasing slightly to $640,000 compared to $543,000 in the prior year period. The company's cash position improved to $3.6 million following a significant issuance of shares and the exercise of stock options during the nine months ended September 30, 2026.
For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets resulting from operations of $109.8 million, primarily driven by $199.2 million in unrealized depreciation on gold investments. Despite the net loss, the Trust saw net creations of $251.4 million, bringing total net assets to approximately $2.68 billion.
Boumarang Inc. reported its first revenue of $200,000 for the quarter ended September 30, 2026, though it continues to operate at a net loss of $480,261 for the quarter. The company is transitioning from R&D to commercialization of its hydrogen-powered WaveDrone product line and recognized a $1,000,000 unrealized gain on private equity investments during the nine-month period.
bioAffinity Technologies reported its Q3 2026 financial results, highlighted by a 79% year-to-date increase in CyPath Lung testing revenue to $1.1 million. The company saw a 100% increase in test unit sales and an 89% increase in the number of ordering physicians compared to the prior year. Management noted continued momentum in commercialization and expansion of its government healthcare distribution network.
Term
Q3 2026
“Our third quarter results reflect the growing clinical adoption of CyPath® Lung as a vital tool for the early detection of lung cancer. With test unit sales doubling year-to-date and a significant increase in our physician base, we are seeing the direct impact of our commercial strategy and the clear need for noninvasive diagnostic solutions in the lung cancer care continuum.”
Maria Zannes, President and Chief Executive Officer
For the nine months ended September 30, 2026, bioAffinity Technologies reported a net loss of $12.3 million on revenue of $3.9 million, compared to a net loss of $11.8 million on revenue of $4.6 million in the prior year period. The company's cash position decreased significantly to $2.6 million from $6.4 million at year-end 2025, driven by increased operating expenses in clinical development and general administration.
Core University Living Real Estate Income Trust Director Marc Chanin Lifshin Sells $5M of Stock
Marc Chanin Lifshin, Director, sold 496,322 shares of Core University Living Real Estate Income Trust at $10.07 a share, worth $5M in total on Oct 1, 2026. Shares held after the trade: 2,625,661 (-15.9%).
Rallybio Corporation has postponed the closing of its previously announced merger with Avenzo Therapeutics, Inc., which was originally expected to close on November 6, 2026. The delay is due to unsatisfied conditions related to the listing of the company's shares following the transaction. Consequently, the company has also delayed the funding and payment of its previously announced cash distribution to shareholders.
Blue Owl Real Estate Net Lease Trust reported total revenues of $159.7 million for the quarter ended September 30, 2026, a significant increase from $66.0 million in the prior year period. Despite higher revenues, net income attributable to shareholders decreased to $63.0 million from $193.1 million, primarily due to a lower contribution from unconsolidated real estate affiliates and increased operating and interest expenses.
Power REIT reported a net loss attributable to common shareholders of $1.08 million for the nine months ended September 30, 2026, compared to a $1.36 million loss in the prior year. The Trust executed a 1-for-10 reverse stock split in June 2026 and saw total assets decrease to $25.5 million from $26.9 million at year-end 2025.
Sidus Space announced that its audited financial statements for fiscal years 2024 and 2025, and quarterly reports for the first half of 2026, should no longer be relied upon due to accounting errors. The errors relate to the misclassification of 3.4 million warrants as equity instead of liabilities and the improper capitalization and depreciation of the LizzieSat 2 satellite, which failed to establish communications after its December 2024 launch. The company expects to restate these financial statements to record a warrant liability of approximately $4.7 million and adjust satellite-related expenses.
Mount Logan Capital Inc. appointed Brandon Harper as Chief Accounting Officer and principal accounting officer, effective November 3, 2026. Mr. Harper, who previously served as the company's Group Controller, succeeds Brandon Satoren in the principal accounting officer role. In connection with the appointment, Mr. Harper received a grant of 7,080 restricted stock units that vest over three years.
Knightscope received a deficiency notice from Nasdaq because its Class A Common Stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until May 3, 2027, to regain compliance by maintaining a bid price of at least $1.00 for ten consecutive business days. The notice does not result in immediate delisting, and the stock continues to trade under the symbol 'KSCP'.
T3 Defense Signs $1.54M M&A Deal with KeepZone AI Inc.
T3 Defense Inc. completed the acquisition of KeepZone AI Inc. from Nexera Technologies Ltd. on November 4, 2026. The purchase price was increased to $1,539,800 and was settled through the issuance of 425,594 shares of T3 Defense common stock.
Mangoceuticals, Inc. received written consent from its Series B Preferred Stock holder to establish a new series of 8% Series D Convertible Cumulative Preferred Stock. The company plans to offer up to 1,000,000 shares of the Series D Preferred Stock at $10.00 per share through a Regulation A offering. The Series B holder also approved an amendment to recognize the senior dividend and liquidation rights of the new Series D shares.
Vogenx, Inc. is a clinical-stage biopharmaceutical company that has incurred significant losses since inception and expects to continue doing so for the foreseeable future. The company currently generates no revenue from product sales and requires substantial additional funding to advance its research and development programs, including its lead candidate mizagliflozin.
TPG Mortgage Investment Trust reported a net loss available to common stockholders of $15.7 million for the third quarter of 2026, primarily driven by $19.9 million in net unrealized losses. Total assets decreased to $7.76 billion from $8.71 billion at year-end 2025, largely due to a reduction in the fair value of securitized residential mortgage loans.
Jazz Pharmaceuticals SVP, CAO Patricia Carr Sells $327K of Stock
Patricia Carr, SVP, CAO, sold 1,413 shares of Jazz Pharmaceuticals plc at $231.27 to $231.37 a share (average $231.36) in 2 transactions, worth $327K in total on Nov 4, 2026. Shares held after the trade: 6,512 (-2.4%).
Quoin Pharmaceuticals reported third quarter 2026 financial results and provided a corporate update, including positive interim Phase 2/3 data for QRX003 in Netherton Syndrome. The company also highlighted a private placement financing of up to $50.0 million to fund the completion of QRX003 development. Topline data for the Netherton Syndrome study is expected in Q2 2027.
“The third quarter substantially strengthened Quoin’s clinical, regulatory and financial foundation for long-term growth. Interim clinical results from our Phase 2/3 study of QRX003 in Netherton Syndrome demonstrated statistical significance for the primary and key secondary endpoints, representing what we believe is the first ever overall positive data set published for this disease.”
Dr. Michael Myers, Chief Executive Officer and Co-Founder
“Our priorities for the coming months are very clear. We expect to complete recruitment in our Netherton Syndrome study by year end and report topline data in the second quarter of 2027.”
Dr. Michael Myers, Chief Executive Officer and Co-Founder
Clean Energy Technologies $2M Debt Financing with FuFront AI Pte. Ltd.
Clean Energy Technologies entered into a securities purchase agreement with FuFront AI Pte. Ltd. for the issuance of a $2.0 million convertible promissory note. The note matures on October 3, 2027, carries a 12% annual interest rate, and is convertible into common stock at a 15% discount to the market price after a six-month holding period.
Auddia Inc. entered into agreements with certain warrant holders to exchange existing warrants for common stock at a ratio of two shares per warrant. The transaction involves an initial exchange of 580,023 warrants for 1.16 million shares, with an additional 4.14 million warrants to be exchanged pending stockholder approval. The exchange is being conducted under Section 3(a)(9) of the Securities Act, meaning no new cash is being raised and no commissions are being paid.
FG Communities Holdings Inc. reported a significant net loss of $57.3 million for the nine months ended September 30, 2026, primarily driven by a $43.7 million loss from discontinued operations. Total assets decreased from $163.8 million to $59.8 million year-over-year, largely due to the disposal of assets related to discontinued operations.
For the quarter ended September 30, 2026, indie Semiconductor reported total revenue of $70.2 million, a 31% increase year-over-year, though it recorded a net loss of $39.9 million. The company is currently managing the pending divestiture of its Wuxi indie Microelectronics interest and reported $134.2 million in cash and cash equivalents.
BioVie Inc. reported a net loss of $5.6 million for the quarter ended September 30, 2026, compared to a $5.1 million loss in the prior year period. The company remains in the clinical stage with no revenue, focusing its spending on research and development for neurodegenerative and liver disease therapies.
Gilead Sciences Chairman & CEO Daniel Patrick O'Day Sells $19.7M of Stock
Daniel Patrick O'Day, Chairman & CEO, sold 112,429 shares of Gilead Sciences, Inc. at $175.16 to $175.17 a share (average $175.16) in 2 transactions, worth $19.7M in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 551,683 (-1.7%).
RenX Enterprises Corp. entered into an exchange agreement with an accredited investor to convert $1.02 million of existing debt into a new senior convertible note and warrants. The new note has a principal amount of $1.04 million, matures in 12 months, and carries a 10% interest rate. This transaction represents a balance-sheet restructuring of existing obligations rather than a new cash capital raise.
Greif, Inc. reported fiscal year 2026 net income of $261.5 million, a significant increase from $31.6 million in the prior year. The company also announced the strategic exit of its Coated Recycled Board business through the closure of the Sweetwater paperboard mill as part of a portfolio optimization strategy. Net debt was reduced by $144.9 million during the year, bringing the company's leverage ratio down to 1.2x.
Heartland Express reported a return to profitability in the third quarter of 2026 with net income of $1.0 million, compared to a net loss of $8.3 million in the prior year period. While operating revenue decreased to $179.5 million from $196.5 million, the company significantly improved its bottom line through a $40.2 million gain on the disposal of property and equipment and reduced operating expenses across most categories.